Envestnet Asset Management Inc. lessened its holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA – Free Report) by 52.0% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 169,349 shares of the pharmacy operator’s stock after selling 183,184 shares during the quarter. Envestnet Asset Management Inc.’s holdings in Walgreens Boots Alliance were worth $1,580,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other hedge funds and other institutional investors have also bought and sold shares of the business. Virtu Financial LLC bought a new position in Walgreens Boots Alliance in the third quarter worth approximately $208,000. Westside Investment Management Inc. lifted its holdings in shares of Walgreens Boots Alliance by 14.3% in the 3rd quarter. Westside Investment Management Inc. now owns 11,587 shares of the pharmacy operator’s stock worth $104,000 after buying an additional 1,454 shares during the period. Wealthquest Corp bought a new position in shares of Walgreens Boots Alliance during the 3rd quarter worth $130,000. Wilmington Savings Fund Society FSB purchased a new position in shares of Walgreens Boots Alliance during the third quarter valued at $92,000. Finally, Franklin Resources Inc. raised its holdings in shares of Walgreens Boots Alliance by 54.4% in the third quarter. Franklin Resources Inc. now owns 321,425 shares of the pharmacy operator’s stock valued at $2,893,000 after acquiring an additional 113,242 shares in the last quarter. Hedge funds and other institutional investors own 58.59% of the company’s stock.
Analysts Set New Price Targets
WBA has been the topic of a number of research reports. StockNews.com began coverage on shares of Walgreens Boots Alliance in a research report on Sunday. They set a “hold” rating on the stock. Truist Financial cut their price objective on shares of Walgreens Boots Alliance from $13.00 to $12.00 and set a “hold” rating on the stock in a report on Friday, January 31st. Royal Bank of Canada boosted their price objective on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock a “sector perform” rating in a research note on Wednesday, January 15th. Bank of America increased their target price on Walgreens Boots Alliance from $7.50 to $8.50 and gave the company an “underperform” rating in a research report on Monday, January 13th. Finally, Wolfe Research raised Walgreens Boots Alliance to a “hold” rating in a research report on Monday, February 24th. Four investment analysts have rated the stock with a sell rating, seven have issued a hold rating and two have issued a buy rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Hold” and an average price target of $10.59.
Walgreens Boots Alliance Price Performance
Shares of NASDAQ WBA opened at $10.97 on Tuesday. Walgreens Boots Alliance, Inc. has a fifty-two week low of $8.08 and a fifty-two week high of $18.83. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.30 and a current ratio of 0.64. The company has a market cap of $9.49 billion, a PE ratio of -1.07, a P/E/G ratio of 1.31 and a beta of 0.67. The business has a 50-day simple moving average of $10.95 and a two-hundred day simple moving average of $10.24.
Walgreens Boots Alliance (NASDAQ:WBA – Get Free Report) last announced its quarterly earnings data on Tuesday, April 8th. The pharmacy operator reported $0.63 EPS for the quarter, beating the consensus estimate of $0.53 by $0.10. The firm had revenue of $38.59 billion during the quarter, compared to analyst estimates of $37.90 billion. Walgreens Boots Alliance had a negative net margin of 5.87% and a positive return on equity of 17.61%. Walgreens Boots Alliance’s revenue was up 4.1% on a year-over-year basis. During the same period last year, the firm posted $1.20 EPS. As a group, equities analysts expect that Walgreens Boots Alliance, Inc. will post 1.6 EPS for the current fiscal year.
About Walgreens Boots Alliance
Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.
Read More
- Five stocks we like better than Walgreens Boots Alliance
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- Best Defense Stocks in 2025… So Far
- How to Read Stock Charts for Beginners
- Alphabet Rebounds After Strong Earnings and Buyback Announcement
- What is a Bond Market Holiday? How to Invest and Trade
- Could Selling Taiwan Semiconductor Be Buffett’s Biggest Regret?
Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBA – Free Report).
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.